ASH is excited to announce this FDA-sponsored session featuring drugs that received FDA approval in November 2015. The FDA product-reviewers will discuss the safety and efficacy issues from the products' clinical trials and toxicity studies. The program will also include clinicians who will discuss their perspectives on the use of the products in the real world setting. The didactic presentations will be short to leave time for audience questions.